Spatial extent of neuronal metabolic dysfunction measured by proton MR spectroscopic imaging in patients with localization-related epilepsy

Epilepsia

Volumn 41, Issue 6, 2000, Pages 666-674

  Li, L M ^a   Cendes, F ^a   Andermann, F ^a   Dubeau, F ^a   Arnold, D L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Axons; Epilepsy; Magnetic resonance spectroscopy; MRI; Neuronal dysfunction

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EPILEPTIC FOCUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE EPILEPSY;

EID: 0034123564     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.2000.tb00226.x     Document Type: Article

References (60)

1. Gadian DG. N-acetylaspartate and epilepsy. Magn Reson Imaging 1995;13:1193-5.
2. Salibi N, Brown MA. Clinical MR spectroscopy: first principles. New York: Wiley-Liss, 1998.
3. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991;45:37-45.
4. Moffett JR, Namboodiri MA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991;2:131-4.
5. 1H nuclear magnetic resonance spectroscopic imaging of neuronal loss in rat brain. Neuroscience 1995;69:1095-101.
6. 1H magnetic resonance spectroscopic imaging analysis of quinolinic acid-induced damage to the rat striatum. Magn Reson Med 1997;37:24-33.
7. Najm IM, Wang Y, Hong SC, Luders HO, Ng TC, Comair YG. Temporal changes in proton MRS metabolites after kainic acid-induced seizures in rat brain. Epilepsia 1997;38:87-94.
8. Najm IM, Wang Y, Shedid D, Luders HO, Ng TC, Comair YG. MRS metabolic markers of seizures and seizure-induced neuronal damage. Epilepsia 1998;39:244-50.
9. 1H magnetic resonance spectroscopic imaging. J Cereb Blood Flow Metab 1994;14:373-82.
10. Tokumitsu T, Mancuso A, Weinstein PR, Weiner MW, Naruse S, Maudsley AA. Metabolic and pathological effects of temporal lobe epilepsy in rat brain detected by proton spectroscopy and imaging. Brain Res 1997;744:57-67.
11. Pioro EP, Wang Y, Moore JK, et al. Neuronal pathology in the wobbler mouse brain revealed by in vivo protein magnetic resonance spectroscopy and immunocytochemistry. Neuroreport 1998; 9:3041-6.
12. Nakano M, Ueda H, Li JY, Matsumoto M, Yanagihara T. Measurement of regional N-acetylasparatate after transient global ischemia in gerbils with and without ischemic tolerance: an index of neuronal survival. Ann Neurol 1998;44:334-40.
13. Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994;44:1933-8.
14. Moller HE, Vermathen P, Lentschig MG, et al. Metabolic characterization of AIDS dementia complex by spectroscopic imaging. J Magn Reson Imaging 1999;9:10-8.
15. Wardlaw JM, Marshall I, Wild J, Dennis MS, Cannon J, Lewis SC. Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. Stroke 1998;29:1618-24.
16. 1H-MR spectroscopic imaging study. Stroke 1995;26:822-8.
17. Petroff OA, Graham GD, Blamire AM, et al. Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology 1992;42:1349-54.
18. Chong WK, Sweeney B, Wilkinson ID, et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 1993;188:119-24.
19. De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995; 34:721-7.
20. Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N-acetylasparate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998;9:1757-61.
21. Balm R, van der Grond J, Mali WP, Eikelboom BC. Reestablishment of cerebral metabolism after carotid endarterectomy. Eur J Vasc Endovasc Surg 1995;10:182-6.
22. van der Grond J, Balm R, Klijn CJ, Kapelle LJ, Eikelboom BC, Mali WP. Cerebral metabolism of patients with stenosis of the internal carotid artery before and after endarterectomy. J Cereb Blood Flow Metab 1996;16:320-6.
23. 1H magnetic resonance spectroscopic imaging. Ann Neurol 1996;40:236-9.
24. Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy: evidence from proton MR spectroscopic imaging. Neurology 1997;49:1525-33.
25. 1H-MRSI follow-up studies of epilepsy show strongly altered metabolite concentrations after surgery [Abstract]. Proc ISMRM 1996;2:957.
26. 1H MR spectroscopic imaging findings in the contralateral temporal lobe following ipsilateral resection in adult temporal lobe epilepsy patients [Abstract]. Neurology 1998;50:A286.
27. Matthews PM, Cianfaglia L, McLaurin J, et al. Demonstration of reversible decreases in N-acetylasparale (NAA) in a neuronal cell line: NAA decreases as a marker of sublethal neuronal dysfunction [Abstract]. Proc ISMRM 1995;1:147.
28. 1H MRS studies in vivo. Neuroreport 1996;7:1397-400.
29. 1H magnetic resonance spectroscopy of extracts of human epileptic neocortex and hippocampus. Neurology 1993;43:589-94.
30. Kauppinen RA, Williams SR. Nuclear magnetic resonance spectroscopy studies of the brain. Prog Neurobiol 1994;44:87-118.
31. 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 1992;24:123-36.
32. 1H magnetic resonance spectroscopy in the investigation of intractable epilepsy. Acta Neurol Scand Suppl 1994;152:116-21.
33. Breiter SN, Arroyo S, Mathews VP, Lesser RP, Bryan RN, Barker PB. Proton MR spectroscopy in patients with seizure disorders. AJNR Am J Neuroradiol 1994;15:373-84.
34. 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo. Magn Reson Imaging 1998;16:969-79.
35. Cendes F, Caramanos Z, Andermann F, Dubeau F, Arnold DL. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann Neurol 1997;42:737-46.
36. Cross JH, Connelly A, Jackson GD, Johnson CL, Neville BG, Gadian DG. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy. Ann Neurol 1996;39:107-13.
37. Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 1994;44:1411-7.
38. 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology 1998;51: 66-71.
39. Ng TC, Comair YG, Xue M, et al. Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. Radiology 1994;193:465-72.
40. Ende GR, Laxer KD, Knowlton RC, et al. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology 1997;202:809-17.
41. Vermathen P, Ende G, Laxer KD, Knowlton RC, Matson GB, Weiner MW. Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy. Ann Neurol 1997;42: 194-9.
42. 1H MRS in vivo. Neuroreport 1994;5:1733-6.
43. Hugg JW, Laxer KD, Matson GB, Maudsley AA, Weiner MW. Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1993;34:788-94.
44. Cendes F, Andermann F, Preul MC, Arnold DL. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Ann Neurol 1994;35:211-6.
45. Engel J Jr, Van Ness P, Rasmussen T, Ojemann LM. Outcome wilh respect to epileptic seizures. In: Engel J, Jr., ed. Surgical treatment of the epilepsies. 2nd ed. New York: Raven Press, 1993:609-21.
46. Stanley JA, Cendes F, Dubeau F, Andermann F, Arnold DL. Proton magnetic resonance spectroscopic imaging in patients with extratemporal epilepsy. Epilepsia 1998;39:267-73.
47. 1H spectroscopic imaging data sets. NMR Biomed 1992;5:171-8.
48. Roth K, Kimber BJ, Feeney J. Data shift accumulation and alternate delay accumulation techniques for overcoming dynamic range problems. J Magn Reson 1980;41:302-9.
49. Petroff OA, Pleban LA, Spencer DD. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartale, glutamate, and GABA content of the epileptic human brain. Magn Reson Imaging 1995;13:1197-211.
50. Hetherington H, Kuzniecky R, Pan J, et al. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol 1995;38:396-404.
51. Watson C, Andermann F, Gloor P, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992;42:1743-50.
52. Cendes F, Andermann F, Gloor P, et al. MRI volumetric measurement of amygdala and hippocampus in temporal lobe epilepsy. Neurology 1993;43:719-25.
53. ILAE. Proposal for revised classification of epilepsies and epileptic syndromes: Commission of Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30: 389-99.
54. Vermathen P, Laxer KD, Schuff N, Maudsley AA, Matson GB, Weiner MW. Simultaneous detection of reduced NAA in hippocampal and other regions in mesial temporal lobe epilepsy using multislice proton MRSI [Abstract]. Proc ISMRM 1998;3:1729.
55. Vermathen P, Laxer KD, El Din M, Matson GB, Weiner MW, Hippocampal NAA loss in mesial temporal lobe epilepsy is not accompanied by changes in other brain regions: a combined multislice and PRESS MRSI study [Abslract]. Proc ISMRM 1997;2: 1185.
56. 1H-magnetic resonance spectroscopy finding mean poor seizure control? J Neurol Neurosurg Psychiatry 1998;65:518-22.
57. Cendes F, Cook MJ, Watson C, et al. Frequency and characteristics of dual pathology in patients with lesional epilepsy. Neurology 1995;45:2058-64.
58. Li LM, Cendes F, Watson C, et al. Surgical treatment of patients with single and dual pathology: relevance of lesion and of hippocampal atrophy to seizure outcome. Neurology 1997;48:437-44.
59. Li LM, Cendes F, Andermann F, et al. Surgical outcome in patients with epilepsy and dual pathology. Brain 1999;122:799-805.
60. Li LM, Cendes F, Antel S, et al. Prognostic features in surgical outcome of patients with bilateral hippocampal atrophy and intractable temporal lobe epilepsy [Abstract]. Neurology 1999;52:161-2.